BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36963600)

  • 41. Clinical utility of cytokine analysis in the diagnosis and efficacy monitoring of vitreoretinal lymphoma.
    Kang H; Tao Y
    Int J Ophthalmol; 2022; 15(12):1893-1902. PubMed ID: 36536977
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical factors for central nervous system progression and survival in primary vitreoretinal lymphoma.
    Motomura Y; Yoshifuji K; Tachibana T; Takase H; Arai A; Tanaka K; Okada K; Nogami A; Umezawa Y; Sakashita C; Yamamoto M; Mori T; Nagao T
    Br J Haematol; 2024 Apr; 204(4):1279-1287. PubMed ID: 38131400
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Secondary Vitreoretinal Lymphoma Masquerading as Acute Retinal Necrosis.
    Ryan ME; Shantha JG; Grossniklaus HE; Yeh S
    Ophthalmic Surg Lasers Imaging Retina; 2015; 46(10):1048-50. PubMed ID: 26599249
    [TBL] [Abstract][Full Text] [Related]  

  • 44. SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY FEATURES OF VITREORETINAL LYMPHOMA IN 55 EYES.
    Yang X; Dalvin LA; Mazloumi M; Ferenczy S; Lim LS; Ancona-Lezama D; Shields JA; Mashayekhi A; Shields CL
    Retina; 2021 Feb; 41(2):249-258. PubMed ID: 32349103
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intravitreal chemotherapy and laser for newly visible subretinal seeds in retinoblastoma.
    Abramson DH; Catalanotti F; Brodie SE; Kellick MG; Francis JH
    Ophthalmic Genet; 2018 Jun; 39(3):353-356. PubMed ID: 29513055
    [TBL] [Abstract][Full Text] [Related]  

  • 46. APRIL and BAFF play a key role in differentiating vitreoretinal lymphoma from uveitis.
    Tian S; Chen K; Xiao J; Wang D; Zhou X; Li X; Shi H; Li Y; Cao X; Guan M; Chen B; Wang Q
    Clin Chim Acta; 2022 Oct; 535():1-6. PubMed ID: 35820532
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intravitreal injection of melphalan for intraocular retinoblastoma.
    Suzuki S; Aihara Y; Fujiwara M; Sano S; Kaneko A
    Jpn J Ophthalmol; 2015 May; 59(3):164-72. PubMed ID: 25808017
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A case of primary intraocular lymphoma treated by intravitreal methotrexate.
    Kim E; Kim C; Lee J; Cho Y
    Korean J Ophthalmol; 2009 Sep; 23(3):210-4. PubMed ID: 19794951
    [TBL] [Abstract][Full Text] [Related]  

  • 49. INTRAVITREOUS CHEMOTHERAPY FOR ACTIVE VITREOUS SEEDING FROM RETINOBLASTOMA: Outcomes After 192 Consecutive Injections. The 2015 Howard Naquin Lecture.
    Shields CL; Douglass AM; Beggache M; Say EA; Shields JA
    Retina; 2016 Jun; 36(6):1184-90. PubMed ID: 26630319
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Advanced OCT Analysis of Biopsy-proven Vitreoretinal Lymphoma.
    Pichi F; Dolz-Marco R; Francis JH; Au A; Davis JL; Fawzi A; Gattousi S; Goldstein DA; Keane PA; Miserocchi E; Marchese A; Ohno-Matsui K; Sagoo MS; Smith SD; Sobol EK; Tasiopoulou A; Yang X; Shields CL; Freund KB; Sarraf D
    Am J Ophthalmol; 2022 Jun; 238():16-26. PubMed ID: 34843686
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intravitreal chemotherapy for vitreous disease in retinoblastoma revisited: from prohibition to conditional indications.
    Munier FL; Gaillard MC; Balmer A; Soliman S; Podilsky G; Moulin AP; Beck-Popovic M
    Br J Ophthalmol; 2012 Aug; 96(8):1078-83. PubMed ID: 22694968
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vitreoretinal presentation of secondary large B-cell lymphoma in patients with systemic lymphoma.
    Salomão DR; Pulido JS; Johnston PB; Canal-Fontcuberta I; Feldman AL
    JAMA Ophthalmol; 2013 Sep; 131(9):1151-8. PubMed ID: 23744124
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical features predictive of vision loss in patients with vitreoretinal lymphoma: a single tertiary center experience.
    Kim M; Suh H; Park YG; Park YH
    Sci Rep; 2023 Mar; 13(1):4478. PubMed ID: 36934118
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intraocular involvement is associated with a high risk of disease relapse in primary central nervous system lymphoma.
    Zhuang L; Lai J; Chen K; Ding T; Yuan Y; Ma Y; Kang H; Lin Z; Fan N; Ma J; Zeng Q; Xu X; Wang Q; Chen B
    Oncol Rep; 2019 Jan; 41(1):397-404. PubMed ID: 30320386
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognosis, Risk Factors, and Clinical Features of Intraocular Recurrence in Primary Vitreoretinal Lymphoma.
    Liu S; Jiang T; Gu J; Zhou X; Chen W; Ping B; Zhou Y; Zhang T; Huang X; Xu G; Chang Q
    Ophthalmol Retina; 2024 Apr; 8(4):317-324. PubMed ID: 37918656
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The diagnostic value of IL-10 and IL-6 level in vitreous fluid and aqueous humor for vitreoretinal lymphoma.
    Chen K; Li X; Wang D; Ma Y; Chen B; Wang Q; Ma J; Guan M
    Clin Chim Acta; 2021 Apr; 515():21-26. PubMed ID: 33387464
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serial Detection of
    Choi S; Shin S; Lee ST; Lee J; Lee JS; Kim B; Lee CS
    Ocul Immunol Inflamm; 2021 Apr; 29(3):485-489. PubMed ID: 32965155
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The classification of vitreous seeds in retinoblastoma and response to intravitreal melphalan.
    Francis JH; Abramson DH; Gaillard MC; Marr BP; Beck-Popovic M; Munier FL
    Ophthalmology; 2015 Jun; 122(6):1173-9. PubMed ID: 25795478
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Next-Generation Sequencing of Vitreoretinal Lymphoma by Vitreous Liquid Biopsy: Diagnostic Potential and Genotype/Phenotype Correlation.
    Kwak JJ; Lee KS; Lee J; Kim YJ; Choi EY; Byeon SH; Chang WS; Kim YR; Kim JS; Shin S; Lee ST; Kim SS; Lee CS
    Invest Ophthalmol Vis Sci; 2023 Nov; 64(14):27. PubMed ID: 37975847
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intravenous high-dose methotrexate based systemic therapy in the treatment of isolated primary vitreoretinal lymphoma: An LOC network study.
    Lam M; Touitou V; Choquet S; Cassoux N; Ghesquières H; Kodjikian L; Schmitt A; Gattoussi S; Tabouret É; Sampo M; Blonski M; Angioi-Duprez K; Houot R; Mouriaux F; Gyan E; Le Lez ML; Moles MP; Croisé F; Chauchet A; Schwartz C; Ahle G; Meyer L; Gressin R; Chiquet C; Oberic L; Ollé P; Marolleau JP; Jany B; Tempescul A; Cochener B; Damaj G; Quintyn JC; Moluçon-Chabrot C; Rousseau E; Franciane P; Schneider C; Massé H; Tamburini-Bonnefoy J; Brézin A; Fornecker LM; Ballonzoli L; Le Garff-Tavernier M; Hoang-Xuan K; Bodaghi B; Soussain C; Houillier C
    Am J Hematol; 2021 Jul; 96(7):823-833. PubMed ID: 33864703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.